mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.008 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.009 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.01 |